Ralaniten triacetate
Ralaniten triacetate (EPI-506) is an orally bioavailable, first-in-class inhibitor targeting the androgen receptor N-terminal domain. It demonstrates anticancer activity and is a valuable research tool for investigating prostate and breast cancer in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1637573-04-6
Product Name Alternative
AndrogenReceptor, Androgen Receptor, EPI-506, Ralaniten
Field of Research
Metabolism Research
Purity
98.69% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (6.33 mM) ; DMSO:80 mg/mL (153.55 mM)
Smiles
CC (=O) OC[C@H] (COc1ccc (cc1) C (C) (C) c1ccc (OC[C@@H] (CCl) OC (C) =O) cc1) OC (C) =O
Molecular Formula
C27H33ClO8
Molecular Weight
521.00
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
043752-FITC 200 µL
VGFR3 (Tyrosine-protein kinase receptor FLT4, VEGFR-3) (FITC) discontinued
Sign In for Pricing
View Details 
GTR15389117 1 Vial
Lentiviral human ANG sgRNA gene knockout kit - Lentiviral human ANG sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details K2443007 1.0 µg DNA
TRAV7 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details